Sofosbuvir add-on to ribavirin treatment for chronic hepatitis e virus infection in solid organ transplant recipients does not result in sustained virological response

E. M. Van Wezel; J. De Bruijne; K. Damman; M. Bijmolen; A. P. Van Den Berg; E. A.M. Verschuuren; G. A. Ruigrok; A. Riezebos-Brilman; M. Knoester

doi:10.1093/ofid/ofz346

Sofosbuvir add-on to ribavirin treatment for chronic hepatitis e virus infection in solid organ transplant recipients does not result in sustained virological response

E. M. Van Wezel^*
, J. De Bruijne
, K. Damman
, M. Bijmolen
, A. P. Van Den Berg
, E. A.M. Verschuuren
, G. A. Ruigrok
, A. Riezebos-Brilman
, M. Knoester

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2 Downloads (Pure)

Abstract

Ribavirin is effective for treating immunocompromised patients with chronic hepatitis E virus infection. However, ribavirin treatment is not always successful. We describe 3 solid organ transplant recipients treated with sofosbuvir and ribavirin after failing ribavirin monotherapy. Complete elimination of hepatitis E virus could not be achieved.

Original language	English
Article number	ofz346
Journal	Open forum infectious diseases
Volume	6
Issue number	8
DOIs	https://doi.org/10.1093/ofid/ofz346
Publication status	Published - 1 Aug 2019

Keywords

chronic hepatitis E
sofosbuvir
solid organ transplant recipients

Access to Document

10.1093/ofid/ofz346

vanwezelFinal published version, 247 KB

Cite this

Van Wezel, E. M., De Bruijne, J., Damman, K., Bijmolen, M., Van Den Berg, A. P., Verschuuren, E. A. M., Ruigrok, G. A., Riezebos-Brilman, A., & Knoester, M. (2019). Sofosbuvir add-on to ribavirin treatment for chronic hepatitis e virus infection in solid organ transplant recipients does not result in sustained virological response. Open forum infectious diseases, 6(8), Article ofz346. https://doi.org/10.1093/ofid/ofz346

@article{6fcf368c71934822a72f06abc845a62e,

title = "Sofosbuvir add-on to ribavirin treatment for chronic hepatitis e virus infection in solid organ transplant recipients does not result in sustained virological response",

abstract = "Ribavirin is effective for treating immunocompromised patients with chronic hepatitis E virus infection. However, ribavirin treatment is not always successful. We describe 3 solid organ transplant recipients treated with sofosbuvir and ribavirin after failing ribavirin monotherapy. Complete elimination of hepatitis E virus could not be achieved.",

keywords = "chronic hepatitis E, sofosbuvir, solid organ transplant recipients",

author = "\{Van Wezel\}, \{E. M.\} and \{De Bruijne\}, J. and K. Damman and M. Bijmolen and \{Van Den Berg\}, \{A. P.\} and Verschuuren, \{E. A.M.\} and Ruigrok, \{G. A.\} and A. Riezebos-Brilman and M. Knoester",

note = "{\textcopyright} The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.",

year = "2019",

month = aug,

day = "1",

doi = "10.1093/ofid/ofz346",

language = "English",

volume = "6",

journal = "Open forum infectious diseases",

issn = "2328-8957",

publisher = "Oxford University Press",

number = "8",

}

Van Wezel, EM, De Bruijne, J, Damman, K, Bijmolen, M, Van Den Berg, AP, Verschuuren, EAM, Ruigrok, GA, Riezebos-Brilman, A & Knoester, M 2019, 'Sofosbuvir add-on to ribavirin treatment for chronic hepatitis e virus infection in solid organ transplant recipients does not result in sustained virological response', Open forum infectious diseases, vol. 6, no. 8, ofz346. https://doi.org/10.1093/ofid/ofz346

Sofosbuvir add-on to ribavirin treatment for chronic hepatitis e virus infection in solid organ transplant recipients does not result in sustained virological response. / Van Wezel, E. M.; De Bruijne, J.; Damman, K. et al.
In: Open forum infectious diseases, Vol. 6, No. 8, ofz346, 01.08.2019.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Sofosbuvir add-on to ribavirin treatment for chronic hepatitis e virus infection in solid organ transplant recipients does not result in sustained virological response

AU - Van Wezel, E. M.

AU - De Bruijne, J.

AU - Damman, K.

AU - Bijmolen, M.

AU - Van Den Berg, A. P.

AU - Verschuuren, E. A.M.

AU - Ruigrok, G. A.

AU - Riezebos-Brilman, A.

AU - Knoester, M.

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Ribavirin is effective for treating immunocompromised patients with chronic hepatitis E virus infection. However, ribavirin treatment is not always successful. We describe 3 solid organ transplant recipients treated with sofosbuvir and ribavirin after failing ribavirin monotherapy. Complete elimination of hepatitis E virus could not be achieved.

AB - Ribavirin is effective for treating immunocompromised patients with chronic hepatitis E virus infection. However, ribavirin treatment is not always successful. We describe 3 solid organ transplant recipients treated with sofosbuvir and ribavirin after failing ribavirin monotherapy. Complete elimination of hepatitis E virus could not be achieved.

KW - chronic hepatitis E

KW - sofosbuvir

KW - solid organ transplant recipients

UR - https://www.scopus.com/pages/publications/85071175454

U2 - 10.1093/ofid/ofz346

DO - 10.1093/ofid/ofz346

M3 - Article

C2 - 31404927

AN - SCOPUS:85071175454

SN - 2328-8957

VL - 6

JO - Open forum infectious diseases

JF - Open forum infectious diseases

IS - 8

M1 - ofz346

ER -

Sofosbuvir add-on to ribavirin treatment for chronic hepatitis e virus infection in solid organ transplant recipients does not result in sustained virological response

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this